2009•Journal of Medicinal ChemistryOpen access

First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery

Maria Menichincheri, Alberto Bargiotti, Jens Berthelsen, Jay Aaron Bertrand, Roberto Tiberio Bossi, Antonella Ciavolella, Alessandra Cirla, Cinzia G. Cristiani, Valter Croci, Roberto D’Alessio, Marina Fasolini, Francesco Fiorentini, Barbara Forte, Antonella Isacchi, Katia Martina, Agnese Molinari, Alessia Montagnoli, Paolo Orsini, Fabrizio Orzi, Enrico A. Pesenti, Daniele Pezzetta, Antonio Pillan, Italo Poggesi, Fulvia Roletto, Alessandra Scolaro, Marco Tatò, Marcellino Tibolla, Barbara Valsasina, Mario Varasi, Daniele Volpi, Corrado Santocanale, Ermes Vanotti

Open full text 1 citations

Abstract

Binding Affinity of the Final Pair of Oxide-Bridged Phenylmorphans, the Ortho-and Para-b-Isomers and Their N-Phenethyl Analogues, and the Synthesis of the N-Phenethyl Analogues of the Ortho-and Para-d-Isomers.

Open-access reader

About this research paper

What this paper is about

Binding Affinity of the Final Pair of Oxide-Bridged Phenylmorphans, the Ortho-and Para-b-Isomers and Their N-Phenethyl Analogues, and the Synthesis of the N-Phenethyl Analogues of the Ortho-and Para-d-Isomers.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Binding Affinity of the Final Pair of Oxide-Bridged Phenylmorphans, the Ortho-and Para-b-Isomers and Their N-Phenethyl Analogues, and the Synthesis of the N-Phenethyl Analogues of the Ortho-and Para-d-Isomers.

Key concepts: Chemistry, Orally active, Lead compound, Pharmacology, Drug discovery, Lead (geology), Enzyme inhibitor, Kinase

Related papers

Back to paper searchBrowse research topicsOriginal source
First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery — Research Paper | ScholarLens